1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Dexamethasone |
| brand | String | Decadron (historical), Dexpak (taper pack), Hemady, Ozurdex (intravitreal) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Corticosteroids|Corticosteroid]] • [[:Category:Glucocorticoids|Glucocorticoid (long-acting • high-potency)]] • [[:Category:Immunosuppressants|Immunosuppressant]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000E23-QINU`"', '"`UNIQ--vote-00000E24-QINU`"', '"`UNIQ--vote-00000E25-QINU`"', '"`UNIQ--vote-00000E26-QINU`"', '"`UNIQ--vote-00000E27-QINU`"', '"`UNIQ--vote-00000E28-QINU`"', '"`UNIQ--vote-00000E29-QINU`"', '"`UNIQ--vote-00000E2A-QINU`"' |
| starting_dose | String | Indication-specific: 0.5-9 mg PO/IV daily for inflammation; 4 mg IV q6h for cerebral edema; 40 mg PO once weekly in MM; 6 mg PO/IV daily ×10 days for severe COVID-19; 0.6 mg/kg PO single dose for croup (max 16 mg) |
| preparations | String | 0.5, 0.75, 1, 1.5, 2, 4, 6 mg tablets; oral solution; 4, 10, 20, 100 mg/mL IV; intravitreal implant (Ozurdex) |
| fda_max | String | Indication-specific |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • IM • intra-articular • intrathecal (rare) • intravitreal |
| onset | String | Hours |
| duration | String | Biologic 36-72 hours (long-acting) |
| halflife | String | Plasma ~3-4.5 hours; biologic ~36-72 hours'"`UNIQ--ref-00000E2B-QINU`"' |
| bioavailability | String | ~80% (oral)'"`UNIQ--ref-00000E2C-QINU`"' |
| pregnancy | String | Used in antenatal lung maturation (24-34 weeks gestation; 6 mg IM q12h × 4 doses); broader use weighs benefits against fetal HPA suppression.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
